---
title: "Roller-coaster rides raise heart rate and momentary synchrony but not the source of social change"
id: "biorxiv-5-hearts-in-sync-on-a-roller-coaster-heart-rate-responses-synchrony-and"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-5-hearts-in-sync-on-a-roller-coaster-heart-rate-responses-synchrony-and"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Roller-coaster rides raise heart rate and momentary synchrony but not the source of social change
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-5-hearts-in-sync-on-a-roller-coaster-heart-rate-responses-synchrony-and
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Field study recorded **heart rate** in 439 amusement-park riders; 418 recordings were usable and analyzed. The cohort rode 19 trains of the Balder roller coaster in Gothenburg, Sweden. Data were aligned to ride start for pairwise comparisons. - Investigators measured self-reported **happiness**, **stress** and **closeness** on 0–10 scales immediately before and after each ride; changes were tested alongside physiology. Happiness and closeness increased after the ride; stress results were collected but not emphasized in the abstract. - Heart rate rose by 15.2 beats per minute during the two-minute ride (95% CI 14.2 to 16.3) and returned to baseline within nine minutes, indicating a short-lived physiological arousal pattern tied to the ride period. - K-means clustering produced two response profiles with a low silhouette score (0.29); clusters did not represent clearly distinct heart-rate curve types. One profile—participants calm in the queue—showed larger and more sustained increases. - Synchrony analyses compared real co-rider pairs with surrogate pairs drawn from different trains, aligned on ride start, to separate coupling between people from the ride-driven component; the real pairs showed a modest synchrony boost. - Pairs where both riders arrived with companions gained more **synchrony** during the ride than surrogate benchmarks (Fisher z 0.096, 95% CI 0.050 to 0.142). Pairs including a solo rider showed a smaller and uncertain boost. - The coupling peaked just after the ride and dissipated within five minutes; synchrony therefore tracked the immediate post-ride interval rather than persisting long-term. - Riders reported being happier (+1.3 points; Cohen's d = 0.87) and feeling closer to the other riders on the train (+2.2 points; d = 0.70) after the ride. The study team found no association between phase-specific heart-rate responses, response profile membership, or synchrony and these psychological changes. - Analyses used linear mixed models. The source did not report additional experimental controls or a non-riding comparison group; the authors explicitly state psychological changes cannot be causally attributed to the ride without a non-riding control. - The study is exploratory and a preprint; it has not undergone peer review. Competing interests were declared absent by the authors.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=yenWJOKfn0VelxriSZvqUHCbm8KF9P2bIjTaNznK3BU-1795217210.8361678-1.2.1.1-E0cZxFFrfIArHUd7MTVxjnifIb0rSPU8sSGFXwCDFATrQcg17AhuoCzvT6HU26Dy) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Hearts in sync on a roller coaster: heart-rate responses, synchrony and psychological change in 439 amusement-park riders [ View ORCID Profile](http://orcid.org/0000-0003-0616-7779)Daniel Berglind, Charlotte Wilén, [ View ORCID Profile](http://orcid.org/0000-0002-7746-102X)Mehedi Hasan, Greta Wilsson, Micael Dahlén doi: https://doi.org/10.64898/2026.11.19.767997 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Daniel Berglind 1 Karolinska Institutet; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BBerglind%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Berglind%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADaniel%2BBerglind%2B) * [ORCID record for Daniel Berglind](http://orcid.org/0000-0003-0616-7779 "Open in new tab") * For correspondence: daniel.berglind@ki.se Charlotte Wilén 1 Karolinska Institutet; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Charlotte%2BWil%C3%A9n%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wil%C3%A9n%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ACharlotte%2BWil%25C3%25A9n%2B) Mehedi Hasan 1 Karolinska Institutet; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mehedi%2BHasan%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hasan%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMehedi%2BHasan%2B) * [ORCID record for Mehedi Hasan](http://orcid.org/0000-0002-7746-102X "Open in new tab") Greta Wilsson 1 Karolinska Institutet; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Greta%2BWilsson%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Wilsson%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AGreta%2BWilsson%2B) Micael Dahlén 2 Stockholm School of Economics * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Micael%2BDahl%C3%A9n%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Dahl%C3%A9n%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMicael%2BDahl%25C3%25A9n%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5982111/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5982111/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5982111/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5982111/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Shared intense experiences are thought to bring people closer, and synchronized physiology is a proposed reason. We examined heart rate and synchrony across ride phases, riders' response profiles, and whether these relate to changes in happiness, stress and closeness. Methods In this exploratory field study we recorded heart rate in 439 riders (418 with usable data) on 19 trains of the Balder roller coaster, Gothenburg, Sweden, and measured happiness, stress and closeness (0-10) just before and after the ride. Real pairs were compared with surrogate pairs from different trains, aligned on ride start, to separate coupling between riders from the ride's own effect. Profiles came from k-means clustering; analyses used linear mixed models. Results Heart rate rose by 15.2 beats per minute (95% CI 14.2 to 16.3) during the two-minute ride and was back at baseline within nine minutes. Heart-rate curves did not form clearly distinct types (two profiles, silhouette 0.29): riders calm in the queue rose more and stayed elevated, while riders already aroused rose less. Pairs in which both riders came with companions gained more synchrony during the ride than the surrogate benchmark (Fisher z 0.096, 95% CI 0.050 to 0.142); for pairs including a solo rider the boost was smaller and uncertain. This coupling peaked just after the ride and was gone five minutes later. Riders reported being happier (+1.3 points, Cohen's d = 0.87) and closer to the other riders on the train (+2.2 points, d = 0.70). Neither phase-specific heart-rate responses, response profile nor synchrony was associated with these changes. Conclusions A short shared thrill coupled riders' heart rates beyond what the ride alone explains, and riders felt happier and closer to others on the train afterwards, but the two ran in parallel. Without a non-riding comparison, the psychological changes cannot be attributed to the ride itself. ### Competing Interest Statement The authors have declared no competing interest. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.12.766040v1 "Mapping Senescence Landscapes in Metabolic Liver Disease Progression") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.19.767997v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.19.767997.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Hearts in sync on a roller coaster: heart-rate responses, synchrony and psychological change in 439 amusement-park riders Daniel Berglind, Charlotte Wilén, Mehedi Hasan, Greta Wilsson, Micael Dahlén bioRxiv 2026.11.19.767997; doi: https://doi.org/10.64898/2026.11.19.767997 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767997v1%26text%3DHearts%2520in%2520sync%2520on%2520a%2520roller%2520coaster%253A%2520heart-rate%2520responses%252C%2520synchrony%2520and%2520psychological%2520change%2520in%2520439%2520amusement-park%2520riders "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767997v1%26t%3DHearts%2520in%2520sync%2520on%2520a%2520roller%2520coaster%253A%2520heart-rate%2520responses%252C%2520synchrony%2520and%2520psychological%2520change%2520in%2520439%2520amusement-park%2520riders "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767997v1%26title%3DHearts%2520in%2520sync%2520on%2520a%2520roller%2520coaster%253A%2520heart-rate%2520responses%252C%2520synchrony%2520and%2520psychological%2520change%2520in%2520439%2520amusement-park%2520riders%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.19.767997v1%26title%3DHearts%2520in%2520sync%2520on%2520a%2520roller%2520coaster%253A%2520heart-rate%2520responses%252C%2520synchrony%2520and%2520psychological%2520change%2520in%2520439%2520amusement-park%2520riders "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.19.767997) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.19.767997v1&count=horizontal&via=&text=Hearts%20in%20sync%20on%20a%20roller%20coaster%3A%20heart-rate%20responses%2C%20synchrony%20and%20psychological%20change%20in%20439%20amusement-park%20riders&counturl=www.biorxiv.org/content/10.64898/2026.11.19.767997v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46171) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20385) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27663) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14303) * [Ecology](https://www.b
## Related Clinical Research

- [Genomic survey reveals extensive biosynthetic gene clusters in Bionectriaceae cacao endophytes](https://medichelpline.com/clinical-feed/biorxiv-0-remarkable-biosynthetic-diversity-in-the-bionectriaceae-uncovering-the-genomic.md)
- [Eukaryotic pol ζ/Rev1 complex drives CG-to-GC transversions and large mutator effect](https://medichelpline.com/clinical-feed/biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome.md)
- [Plasma P-tau217, NfL and GFAP Predict Cognitive and Functional Decline in Early Sporadic Parkinson](https://medichelpline.com/clinical-feed/medrxiv-1-plasma-neurodegeneration-biomarkers-and-clinical-progression-in-early-sporadic.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [Context-dependent roles of DJ-1 (PARK7) in oxidative-stress diseases: neuroprotection versus tumor](https://medichelpline.com/clinical-feed/pubmed-43059404.md) (DOI: 10.3892/mmr.2026.14076)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.